More than two sides of a coin? How to detect the multiple activities of type 2 transglutaminase.
作者： Carlo Rodolfo , Laura Falasca , Giuseppina Di Giacomo , Pier Giorgio Mastroberardino , Mauro Piacentini
DOI: 10.1016/S0076-6879(08)01410-9
关键词:
摘要: Programmed cell death (PCD) by apoptosis has been widely characterized as a process in which the expression and protein activation of gene must be regulated very precise way order to achieve elimination dying without disturbing neighborhoods. One first genes observed induced during onset PCD is one coding for type 2 transglutaminase (TG2). Since late 1990s, unveiling different new properties enzymatic activities suggested involvement TG2 variety cellular processes other than rendered study this more complicated.
elsevier.com
sci-hub.se 参考文章(23)
Mauro Piacentini, Alessandra Amendola, Fabiola Ciccosanti, Laura Falasca, Maria Grazia Farrace, Pier Giorgio Mastroberardino, Roberta Nardacci, Serafina Oliverio, Lucia Piredda, Carlo Rodolfo, Francesco Autuori, Type 2 transglutaminase and cell death. Progress in Experimental Tumor Research. ,vol. 38, pp. 58- 74 ,(2005) , 10.1159/000084233
László Fésüs, Zoltán Nemes, Daniel Aeschlimann, Susanne Saurer, Mats Paulsson, Robert R. Friis, Expression and activation of tissue transglutaminase in apoptotic cells of involuting rodent mammary tissue European Journal of Cell Biology. ,vol. 70, pp. 125- 133 ,(1996)
Pier Giorgio Mastroberardino, Maria Grazia Farrace, Irene Viti, Flaminia Pavone, Gian Maria Fimia, Gennaro Melino, Carlo Rodolfo, Mauro Piacentini, “Tissue” transglutaminase contributes to the formation of disulphide bridges in proteins of mitochondrial respiratory complexes Biochimica et Biophysica Acta. ,vol. 1757, pp. 1357- 1365 ,(2006) , 10.1016/J.BBABIO.2006.07.007
Laszlo Lorand, Robert M. Graham, Transglutaminases: crosslinking enzymes with pleiotropic functions Nature Reviews Molecular Cell Biology. ,vol. 4, pp. 140- 156 ,(2003) , 10.1038/NRM1014
Suresh Mishra, Liam J. Murphy, Tissue transglutaminase has intrinsic kinase activity: identification of transglutaminase 2 as an insulin-like growth factor-binding protein-3 kinase. Journal of Biological Chemistry. ,vol. 279, pp. 23863- 23868 ,(2004) , 10.1074/JBC.M311919200
Craig D.C Bailey, Robert M Graham, Nisha Nanda, Peter J.A Davies, Gail V.W Johnson, Validity of mouse models for the study of tissue transglutaminase in neurodegenerative diseases Molecular and Cellular Neuroscience. ,vol. 25, pp. 493- 503 ,(2004) , 10.1016/J.MCN.2003.11.016
Francesco Facchiano, Antonio Facchiano, Angelo M Facchiano, The role of transglutaminase-2 and its substrates in human diseases Frontiers in Bioscience. ,vol. 11, pp. 1758- 1773 ,(2006) , 10.2741/1921
Amit Verma, Kapil Mehta, Tissue transglutaminase-mediated chemoresistance in cancer cells Drug Resistance Updates. ,vol. 10, pp. 144- 151 ,(2007) , 10.1016/J.DRUP.2007.06.002
Roberta Nardacci, Fabiola Ciccosanti, Laura Falasca, Oreste Lo Iacono, Alessandra Amendola, G Antonucci, Mauro Piacentini, Tissue transglutaminase in HCV infection Cell Death & Differentiation. ,vol. 10, ,(2003) , 10.1038/SJ.CDD.4401112
Vincenzo De Laurenzi, Gerry Melino, Gene Disruption of Tissue Transglutaminase Molecular and Cellular Biology. ,vol. 21, pp. 148- 155 ,(2001) , 10.1128/MCB.21.1.148-155.2001